Mutational landscape (excluding “driver” mutations) in patients with MPN-AP/BP (N = 122, 14 in AP and 108 in BP). Data shown in the plot were reported by McNamara and colleagues [88]. MPN-AP, myeloproliferative neoplasm in accelerated phase; MPN-BP, myeloproliferative neoplasm in blast phase.